Beskrivelse
refractory nocturia in patients older than 65 years", UROLOGY, BELLE MEAD, NJ, US, vol.59, no.4, 1 April 2002 (2002-04-01), pages 485-489, XP002720377, ISSN: 0090-4295, DOI:
10.1016/S0090-4295(01)01645-4, HARRIS A S: "Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions", THE JOURNAL OF PEDIATRICS APR 1989, vol.114, no.4 Pt 2, April 1989 (1989-04) , pages 711-718, XP002761170, ISSN: 0022-3476, VANDE WALLE J G BOGAERT G A MATTSSON S SCHURMANS T HOEBEKE P DEBOE V NORGAARD J P ET AL: "A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis", BJU INTERNATIONAL, BLACKWELL SCIENCE, OXFORD, GB, vol. 97, no.3, 1 March 2006 (2006-03-01), pages 603-609, XP002720304, ISSN: 1464-4096, DOI: 10.1111/J.1464-410X.2006.05999.X [retrieved on 2006-02-10]
Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 925400262
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.05.21, US 55120 P
HARRIS A S: "Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions", THE JOURNAL OF PEDIATRICS APR 1989, vol. 114, no. 4 Pt 2, April 1989 (1989-04) , pages 711-718, XP002761170, ISSN: 0022-3476 (B1)
HILTON P ET AL: "The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female", BRITISH JOURNAL OF UROLOGY JUN 1982, vol. 54, no. 3, June 1982 (1982-06), pages 252-255, XP002761201, ISSN: 0007-1331 (B1)
HVISTENDAHL G M ET AL: "The pharmacokinetics of 400 .mu.g of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect", BJU INTERNATIONAL, BLACKWELL SCIENCE, OXFORD, GB, vol. 95, no. 6, 1 April 2005 (2005-04-01), pages 804-809, XP002720305, ISSN: 1464-4096, DOI: 10.1111/J.1464-410X.2005.05405.X [retrieved on 2005-03-24] (B1)
WO-A-2005/046707 (B1)
US-A1- 2005 232 997 (B1)
VAN KERREBROECK ET AL: "Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study", EUROPEAN UROLOGY, ELSEVIER BV, NL, vol. 52, no. 1, 4 June 2007 (2007-06-04), pages 221-229, XP022105013, ISSN: 0302-2838 (B1)
VANDE WALLE J G BOGAERT G A MATTSSON S SCHURMANS T HOEBEKE P DEBOE V NORGAARD J P ET AL: "A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis", BJU INTERNATIONAL, BLACKWELL SCIENCE, OXFORD, GB, vol. 97, no. 3, 1 March 2006 (2006-03-01), pages 603-609, XP002720304, ISSN: 1464-4096, DOI: 10.1111/J.1464-410X.2006.05999.X [retrieved on 2006-02-10] (B1)
KUO HANN-CHORNG: "Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years", UROLOGY, BELLE MEAD, NJ, US, vol. 59, no. 4, 1 April 2002 (2002-04-01), pages 485-489, XP002720377, ISSN: 0090-4295, DOI: 10.1016/S0090-4295(01)01645-4 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende, AR261745726
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 16. avg. år (EP) | 2024.05.21 | 6760 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 15. avg. år (EP) | 2023.05.19 | 4850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2022.05.18 | 4500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2021.05.20 | 4200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2020.05.22 | 3850 | 1/IPAN GMBH | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2019.05.23 | 3500 | 1/IPAN GMBH | Betalt og godkjent |
31809034 expand_more expand_less | 2018.06.20 | 5500 | OSLO PATENTKONTOR AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Årsavgift 10. avg. år (EP) | 2018.05.16 | 3200 | OSLO PATENTKONTOR AS | Betalt og godkjent |